Clinical Trial Update: Early Use of Botulinum Toxin in Spasticity Post Stroke. [Phase 2]

View source ↗

Summary

Phase 2 trial results show early use of botulinum toxin to manage post-stroke spasticity; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity
• Stroke

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Sandwell & West Birmingham Hospitals NHS Trust | Conditions: Stroke, Muscle Spasticity | Phase 2 | Status: COMPLETED